| CTRI Number |
CTRI/2024/08/073006 [Registered on: 28/08/2024] Trial Registered Prospectively |
| Last Modified On: |
27/08/2024 |
| Post Graduate Thesis |
Yes |
| Type of Trial |
Interventional |
|
Type of Study
|
Drug Dentistry |
| Study Design |
Randomized, Parallel Group, Active Controlled Trial |
|
Public Title of Study
|
Comparison of Simvastatin Enhanced Titanium prepared platelet rich fibrin Scaffold and Standard Titanium prepared platelet rich scaffold on Bone changes Around Implants |
|
Scientific Title of Study
|
Efficacy of Titanium prepared Platelet rich fibrin(T-PRF)
scaffold loaded with Simvastatin versus
Titanium prepared Platelet rich fibrin(T-PRF) on
peri implant bone changes a randomized controlled clinical trial |
| Trial Acronym |
NIL |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| NIL |
NIL |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
DR Uma S |
| Designation |
PG Student |
| Affiliation |
Meenakshi Ammal Dental College and Hospital |
| Address |
Room no: 7, Second floor, Department of Periodontology, Meenakshi Ammal Dental college and Hospital, Alapakkam Main Road, Maduravoyal, Chennai.
Chennai TAMIL NADU 600095 India |
| Phone |
8056029914 |
| Fax |
|
| Email |
dr.umasiva@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
DR Vijayalakshmi R |
| Designation |
Professor |
| Affiliation |
Meenakshi Ammal Dental College and Hospital |
| Address |
Room No:7,Second floor, Department of Periodontology, Meenakshi Ammal Dental College and Hospital, Alapakkam main road, Maduravoyal, Chennai.
Chennai TAMIL NADU 600095 India |
| Phone |
9444765440 |
| Fax |
|
| Email |
rajaramvijayalakshmi@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
DR Uma S |
| Designation |
PG Student |
| Affiliation |
Meenakshi Ammal Dental College and Hospital |
| Address |
Room No:7, Second floor, Department of Periodontology, Meenakshi Ammal Dental College and Hospital, Alapakkam main road, Maduravoyal, Chennai.
Chennai TAMIL NADU 600095 India |
| Phone |
8056029914 |
| Fax |
|
| Email |
dr.umasiva@gmail.com |
|
|
Source of Monetary or Material Support
|
| Meenakshi Ammal Dental College and Hospital, Alapakkam main road, Maduravoyal, Chennai-95 |
|
|
Primary Sponsor
|
| Name |
Meenakshi Ammal Dental College and Hospital |
| Address |
Alapakkam Road, Maduravoyal, Chennai-600095 |
| Type of Sponsor |
Research institution and hospital |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 1 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| DR UMA S |
Meenakshi Ammal Dental College and Hospital |
Room No: 7, Second floor, Department of Periodontology, Meenakshi Ammal Dental college and Hospital,
Alapakkam main road, Maduravoyal, Chennai - 600095 Chennai TAMIL NADU |
8056029914
dr.umasiva@gmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 1 |
| Name of Committee |
Approval Status |
| Institutional Ethical committee Meenakshi Ammal Dental college and Hospital |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: K069||Disorder of gingiva and edentulousalveolar ridge, unspecified, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Simvastatin loaded in Titanium prepared platelet rich fibrin |
Titanium prepared platelet rich fibrin is loaded with simvastatin 1.2mg and placed in osteotomy site for implant placement for 6 months |
| Comparator Agent |
Titanium prepared platelet rich fibrin |
Titanium prepared platelet rich fibrin is placed in osteotomy site for implant placements for 6 months |
|
|
Inclusion Criteria
|
| Age From |
20.00 Year(s) |
| Age To |
60.00 Year(s) |
| Gender |
Both |
| Details |
Systemically healthy patients.
Partially edentulous patient with missing posterior teeth. |
|
| ExclusionCriteria |
| Details |
Patients who are pregnant and lactating.
Patients with history of bone metabolic disease.
Patients currently taking drug that can influence bone metabolism.
Use of bisphosphonates in last 4 years.
Patients who are smokers.
|
|
|
Method of Generating Random Sequence
|
Coin toss, Lottery, toss of dice, shuffling cards etc |
|
Method of Concealment
|
Alternation |
|
Blinding/Masking
|
Participant and Investigator Blinded |
|
Primary Outcome
|
| Outcome |
TimePoints |
| Peri implant bone changes |
Day 0(The day of implant placement) and at 6 month |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
| Mean crestal bone changes after implant loading |
At 12th month |
|
|
Target Sample Size
|
Total Sample Size="16" Sample Size from India="16"
Final Enrollment numbers achieved (Total)= "16"
Final Enrollment numbers achieved (India)="16" |
|
Phase of Trial
|
Phase 3 |
|
Date of First Enrollment (India)
|
09/09/2024 |
| Date of Study Completion (India) |
12/03/2025 |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Date Missing |
|
Estimated Duration of Trial
|
Years="1" Months="0" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Completed |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
The aim of the study is to compare the efficacy of Titanium-prepared Platelet rich Fibrin (T-PRF) scaffold
loaded with Simvastatin and Titanium-prepared Platelet rich Fibrin alone on periimplant bone changes in patients undergoing implant placement using randomized control trial method. 16 systemically healthy patients will be randomly selected and 8 patients will be allotted to Group-A and remaining 8 will be allotted to Group-B. Group-A patients will receive T-PRF scaffold loaded with 1.2 mg Simvastatin in the osteotomy site during implant placement and Group-B patients will receive T-PRF scaffold alone during implant placement. CBCT will be taken for all the patients on Day-0 and at 6 months to assess the peri-implant bone changes. |